Dr. Harald Hübner

Lehrstuhl für Pharmazeutische Chemie

Design of Drug Efficacy Guided by Free Energy Simulations of the β2-Adrenoceptor (2023) Panel N, Vo DD, Kahlous NA, Hübner H, Tiedt S, Matricon P, Pacalon J, et al. Journal article Synthesis, Characterization, and Application of Muscarinergic M-3 Receptor Ligands Linked to Fluorescent Dyes (2022) Köckenberger J, Fischer O, Konopa A, Bergwinkl S, Mühlich S, Gmeiner P, Kutta RJ, et al. Journal article Structure-based discovery of nonopioid analgesics acting through the α2A-adrenergic receptor (2022) Fink EA, Xu J, Hübner H, Braz JM, Seemann P, Avet C, Craik V, et al. Journal article Photochromic Fentanyl Derivatives for Controlled mu-Opioid Receptor Activation (2022) Lahmy R, Hübner H, Schmidt M, Lachmann D, Gmeiner P, König B Journal article Development of disulfide-functionalized peptides covalently binding G protein-coupled receptors (2022) Einsiedel J, Schmidt M, Hübner H, Gmeiner P Journal article Structural insights into ligand recognition, activation, and signaling of the α2Aadrenergic receptor (2022) Xu J, Cao S, Hübner H, Weikert D, Chen G, Lu Q, Yuan D, et al. Journal article Structure-Based Evolution of G Protein-Biased μ-Opioid Receptor Agonists (2022) Wang H, Hetzer F, Huang W, Qu Q, Meyerowitz J, Kaindl J, Hübner H, et al. Journal article Functionally selective activation of the dopamine receptor D2 is mirrored by the protein expression profiles (2021) Wenk D, Ignatchenko V, Macklin A, Hübner H, Gmeiner P, Weikert D, Pischetsrieder M, Kislinger T Journal article Optimizing the expression of human dopamine receptors in escherichia coli (2021) Boritzki V, Hübner H, Allikalt A, Gmeiner P, Wöhrl BM Journal article Abolishing Dopamine D2long/D3Receptor Affinity of Subtype-Selective Carbamoylguanidine-Type Histamine H2Receptor Agonists (2021) Tropmann K, Bresinsky M, Forster L, Mönnich D, Buschauer A, Wittmann HJ, Hübner H, et al. Journal article